or Try an Advanced Search...

    Antisense RNA Stocks List

    Symbol Grade Name % Change
    SRPT B Sarepta Therapeutics, Inc. 0.03
    IONS B Ionis Pharmaceuticals, Inc. 0.91
    PRAX D Praxis Precision Medicines, Inc. 4.02
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Dystrophy Huntington's Disease Ionis Rare Diseases Spinal Muscular Atrophy Therapeutic Gene Modulation Acromegaly Alcohol Alport Syndrome Amyloid Amyloidosis Angioedema Apatorsen Biology Biotechnology Cancer Cardiomyopathy Central Nervous System Disorders Cholesterol

    Related ETFs - A few ETFs which own one or more of the above listed Antisense RNA stocks.

    Symbol Grade Name Weight
    PINK A Simplify Health Care ETF 10.39
    IDNA D iShares Genomics Immunology and Healthcare ETF 5.39
    IBRN C iShares Neuroscience and Healthcare ETF 5.03
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.18
    BTEC B Principal Healthcare Innovators Index ETF 3.76
    View all Antisense RNA ETFs...
    Compare ETFs
    Compare ARKG to BTEC Compare PINK to BTEC Compare PINK to IBRN

        Antisense RNA Stocks Recent News

        Date Stock Title
        Jun 27 SRPT Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
        Jun 26 IONS FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
        Jun 26 SRPT Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.
        Jun 26 SRPT Sarepta cut to Neutral at Citi on risks to valuation
        Jun 26 SRPT Insider Sale: EVP, General Counsel Ryan Brown Sells 38,957 Shares of Sarepta Therapeutics Inc (SRPT)
        Jun 25 IONS Ionis gains as anti-lipid therapy undergoes FDA priority review
        Jun 25 IONS Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
        Jun 25 IONS Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
        Jun 24 SRPT Sarepta Therapeutics Scores 90-Plus RS Rating On Muscular Dystrophy Approval
        Jun 24 SRPT Micron To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Monday
        Jun 24 SRPT Company News for Jun 24, 2024
        Jun 24 SRPT Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?
        Jun 23 SRPT DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Dystrophy Huntington's Disease Ionis Rare Diseases Spinal Muscular Atrophy Therapeutic Gene Modulation Acromegaly Alcohol Alport Syndrome Amyloid Amyloidosis Angioedema Apatorsen Biology Biotechnology Cancer Cardiomyopathy Central Nervous System Disorders Cholesterol
        Antisense RNA

        Browse All Tags